The neuronal metabolite NAA regulates histone H3 methylation in oligodendrocytes and myelin lipid composition
Autor: | A. Daniels, Leah P. Shriver, Robert Clements, E. E. Kooijman, Peter Bannerman, Shuo Li, Jennifer McDonough, He Huang, Naveen Kumar Singhal, Fuzheng Guo, Travis Burns, David E Pleasure, Ernest J. Freeman, J. Gadd |
---|---|
Rok vydání: | 2016 |
Předmět: |
Central Nervous System
Male 0301 basic medicine Neurodegenerative Inbred C57BL Medical and Health Sciences Transgenic Histone methylation Histones Mice Myelin Myelin lipids N-acetylaspartate 0302 clinical medicine Tandem Mass Spectrometry Cells Cultured Myelin Sheath Neurons Chromatography Liquid Cultured Oligodendrocytes Chemistry General Neuroscience Cell biology Oligodendroglia medicine.anatomical_structure Neurological Ketoglutaric Acids Female Sphingomyelin Multiple Sclerosis Cells 1.1 Normal biological development and functioning Mice Transgenic Autoimmune Disease Methylation Article White matter 03 medical and health sciences Histone H3 Underpinning research Acetyltransferases mental disorders Genetics medicine Animals Humans Histone demethylase activity Aspartic Acid Neurology & Neurosurgery Mass spectrometry Psychology and Cognitive Sciences Neurosciences Oligodendrocyte Brain Disorders nervous system diseases Aspartoacylase Mice Inbred C57BL 030104 developmental biology Gene Expression Regulation nervous system Postmortem Changes Neuroscience 030217 neurology & neurosurgery Chromatography Liquid |
Zdroj: | Experimental brain research, vol 235, iss 1 |
ISSN: | 1432-1106 0014-4819 |
Popis: | The neuronal mitochondrial metabolite N-acetylaspartate (NAA) is decreased in the multiple sclerosis (MS) brain. NAA is synthesized in neurons by the enzyme N-acetyltransferase-8-like (NAT8L) and broken down in oligodendrocytes by aspartoacylase (ASPA) into acetate and aspartate. We have hypothesized that NAA links the metabolism of axons with oligodendrocytes to support myelination. To test this hypothesis, we performed lipidomic analyses using liquid chromatography-tandem mass spectrometry (LC-MS/MS) and high-performance thin-layer chromatography (HPTLC) to identify changes in myelin lipid composition in postmortem MS brains and in NAT8L knockout (NAT8L-/-) mice which do not synthesize NAA. We found reduced levels of sphingomyelin in MS normal appearing white matter that mirrored decreased levels of NAA. We also discovered decreases in the amounts of sphingomyelin and sulfatide lipids in the brains of NAT8L-/- mice compared to controls. Metabolomic analysis of primary cultures of oligodendrocytes treated with NAA revealed increased levels of α-ketoglutarate, which has been reported to regulate histone demethylase activity. Consistent with this, NAA treatment resulted in alterations in the levels of histone H3 methylation, including H3K4me3, H3K9me2, and H3K9me3. The H3K4me3 histone mark regulates cellular energetics, metabolism, and growth, while H3K9me3 has been linked to alterations in transcriptional repression in developing oligodendrocytes. We also noted the NAA treatment was associated with increases in the expression of genes involved in sulfatide and sphingomyelin synthesis in cultured oligodendrocytes. This is the first report demonstrating that neuronal-derived NAA can signal to the oligodendrocyte nucleus. These data suggest that neuronal-derived NAA signals through epigenetic mechanisms in oligodendrocytes to support or maintain myelination. |
Databáze: | OpenAIRE |
Externí odkaz: |